CC-90001
Cat. No.:YN350287
CAS No. :1403859-14-2
产品名称: | CC-90001 |
CAS No.: | 1403859-14-2 |
Chemical Name: | |
Synonyms: | 2-(tert-butylamino)-4-[[(1R,3R,4R)-3-hydroxy-4-methylcyclohexyl]amino]pyrimidine-5-carboxamide;2-(tert-butylamino)-4-{[(1R,3R,4R)-3-hydroxy-4-methylcyclohexyl]amino}pyrimidine-5-carboxamide;2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylami |
分子量: | 321.4179 |
分子式: | C16H27N5O2 |
SMILES: | O([H])[C@]1([H])C([H])([H])[C@@]([H])(C([H])([H])C([H])([H])[C@@]1([H])C([H])([H])[H])N([H])C1C(C(N([H])[H])=O)=C([H])N=C(N([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])N=1 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | CC-90001 是一种有效,选择性和具有口服活性的 c-Jun N 末端激酶 (JNK) 抑制剂。CC-90001 在基于细胞的模型中显示出对JNK1的选择性是JNK2的 12.9 倍。CC-90001 可用于特发性肺纤维化的研究。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |